What is leukemia?
What is acute lymphoblastic leukemia?
What causes acute lymphoblastic leukemia?
Who gets acute lymphoblastic leukemia?
What are the common symptoms at diagnosis?
How is acute lymphoblastic leukemia diagnosed?
How is acute lymphoblastic leukemia treated?
What are the complications?
What research is being done?
Links to other information
Linda C. Stork, M.D.
Associate Professor, Pediatrics
University of Colorado School of Medicine
Pediatric Oncologist, The Children's Hospital
Leukemia is a cancer of the blood cells that begins in the bone marrow or the lymph glands where the blood cells are made. Bone marrow occupies the center of all bones, especially bones of the pelvis, the lower spine, and the thighs. Lymph nodes are all over the body, but they usually are too small to feel.
Like all cancers, leukemia is caused by uncontrolled cell division and growth. There are "signals" and "switches" within the genetic material and proteins of each cell of the body that strictly control whether the cells start or stop dividing to make more cells. For example, when a finger is cut, these "signals" and "switches" tell the skin cells to regrow just enough to replace the area of damaged skin and then to stop, without forming big lumps of skin.
Leukemia usually develops in the white blood cells that normally circulate through the blood stream and the lymph nodes to defend the body against infection. Leukemia begins in one cell whose "signals" and "switches" have stopped working correctly. This one abnormal cell divides into two abnormal cells, which divide into more and more abnormal cells. These leukemia cells eventually fill up the bone marrow space, thereby crowding out normal bone marrow cells and spreading into the blood stream and the lymph nodes. As a result, the cells that carry oxygen (red blood cells), the cells that help clot blood (platelets), and the normal white cells that fight infection are reduced greatly in number.
Acute lymphoblastic leukemia is the most common leukemia and cancer of childhood. The word "acute" refers to the fact that patients diagnosed with this leukemia in the early 20th century survived for only a short time. The word "lymphoblastic" refers to the type of white cell that has become cancer. Normal lymphoblasts mature over days to weeks into lymphocytes that defend against infection. Lymphoblasts of leukemia cannot mature or fight infection.
The cause of this type of leukemia is unknown; therefore, it cannot be prevented at the present time. Several changes that occur in a normal lymphocyte over a period of time probably turn it into a leukemic cell. For some cases of acute lymphoblastic leukemia, the first change occurs in fetal life before birth.
Exposure to electrical power lines, toxic chemicals, radon, or radiation has not been proven to cause this leukemia. Although a specific virus causes leukemia in cats, viruses do not appear to cause acute lymphoblastic leukemia in children. This type of leukemia does not appear to be inherited because it very rarely occurs in more than one child per family.
Acute lymphoblastic leukemia is rare. Its incidence is fairly similar worldwide. In the United States, about 3,000 children are diagnosed with this disease each year. For children between infancy and 15 years, acute lymphoblastic leukemia occurs yearly in 1 child among every 25,000 children. For patients aged 2 to 6 years, acute lymphoblastic leukemia occurs yearly in 1 child among every 5,000 to 10,000 children. Although very rare, even newborns and adults can develop acute lymphoblastic leukemia. In the United States, acute lymphoblastic leukemia is much less common among African Americans than Caucasians; however, the reason for this difference is unclear.
The symptoms of acute lymphoblastic leukemia often mimic more common illnesses of childhood. These symptoms are related to reduced numbers of normal bone marrow and blood cells. Patients develop anemia because of low numbers of the red blood cells; they often appear pale with fast heart rates, and, sometimes, they feel lightheaded and tire out easily. Patients with acute lymphoblastic leukemia often bruise more easily and get more nosebleeds because the cells that clot blood (platelets) are low in number. Patients often have several weeks of unexplained fever before acute lymphoblastic leukemia is diagnosed. Sometimes, these fevers are because of infections; other times, they are because of the leukemia itself. About 25% of patients experience bone pain for days to weeks before the diagnosis, especially in the pelvis, the spine, and the legs. About 50% of patients develop swollen lymph nodes in the neck, under the armpits, or in the groin. The liver and the spleen, usually tucked beneath the right and left lower rib cage in the abdomen, can enlarge and become painful as leukemic cells fill the many blood vessels within these organs. Occasionally, a boy's testicles swell as leukemic cells invade them. The lymph nodes deep within the chest may become swollen with leukemic cells, causing a child to breathe faster and harder than normal.
The symptoms described above will prompt a physician to draw the child's blood for a complete blood count (CBC). Often, this CBC shows that the number of red blood cells, and/or platelets, and/or type of white cell called "neutrophils" is low. The total number of white cells in the CBC may range from very low to very high. The lymphoblasts may be recognized on the blood smear when viewed in the laboratory under the microscope.
The final diagnosis of acute lymphoblastic leukemia is made by a bone marrow examination. The bone marrow procedure entails placing a needle into the pelvic bone a few inches to the right or left of the spine and a few inches above the buttocks. This needle goes through the skin, the muscle, and the bone, and into the bone marrow space. From here, liquid bone marrow, filled with leukemic cells, is aspirated into an attached syringe. The bone marrow aspiration procedure is painful; a child usually is sedated and given pain medicine during the procedure.
Children with symptoms similar to those of patients with leukemia may have a different diagnosis. In those cases, the CBC is either completely normal or has abnormalities of only one blood cell type. Certain viral infections, joint diseases, or other blood diseases can mimic the symptoms of leukemia. Occasionally, children with acute lymphoblastic leukemia have symptoms of fever and bone or joint pain and a completely normal CBC. In such cases, the diagnosis is uncertain until the bone marrow aspiration shows the leukemia.
If untreated, acute lymphoblastic leukemia is a fatal disease. However, with modern day treatment, the majority of children with acute lymphoblastic leukemia are cured. Since the 1960s, many children with acute lymphoblastic leukemia and other cancers have participated in randomized clinical trials sponsored by national cooperative organizations, such as the Children's Cancer Group and the Pediatric Oncology Group. Major progress in the treatment of childhood cancers has been made because of the research efforts of these groups.
Children with leukemia are treated by pediatric oncologists and nurses in specialized facilities; patients and families usually are supported by social workers and child life specialists.
The medicines used to treat leukemia and other cancers are called chemotherapy. Chemotherapy drugs can be taken by mouth or injected into the blood stream through a vein, into soft tissue, or into muscle. Because leukemic cells tend to "hide out" in the lining of the brain and the spine, specific chemotherapy is injected into the spinal fluid by a procedure called a lumbar puncture. This procedure involves inserting a small needle into a space between two vertebrae of the lower spine, removing some spinal fluid, and injecting chemotherapy into the spinal fluid space. This procedure usually is performed with topical anesthetic and sedation.
Some of the chemotherapy drugs originally came from products of nature, such as the periwinkle and may apple plant or the bark of the yew tree, or from microorganisms, such as fungus. Other chemotherapy drugs were designed in laboratories. The first chemotherapy drug was developed in the late 1940s. Before that time, patients with acute lymphoblastic leukemia did not survive; all of them died of infection or bleeding within several months of diagnosis.
Treatment of acute lymphoblastic leukemia has evolved during the past 40 years; today, a child may receive up to 15 different chemotherapy drugs during a 2- to 3-year period. Occasionally, radiation therapy is given to the brain. After the first month of treatment, the child is usually in "remission"; 99% of the leukemia cells have been killed, and the CBC and the bone marrow look normal. During the next 2 to 3 years of treatment, chemotherapy attempts to kill the remaining 1% of leukemic cells, which are heartier than those initially killed.
For at least 70% of children, the leukemia never reappears, and these children grow up normally. If the leukemia recurs, it is called a "relapse" and is found in the blood and the bone marrow, the spinal fluid, or the testicles. A relapse can occur any time after remission, but it usually is between 18 months and 5 years after the initial diagnosis. A CBC is performed frequently, along with a physical exam, throughout the course of treatment and for many years thereafter to document continued remission or to diagnose a relapse. About 50% of patients who relapse can be cured with either bone marrow transplantation or several more years of intensive therapy.
Most patients require treatment with antibiotics and transfusions of red blood cells and platelets at diagnosis and during treatment. Once a child is in remission, complications of treatment are from side effects of chemotherapy and not from the leukemia itself. Chemotherapy drugs circulate throughout the entire blood stream and affect normal cells, especially those cells that are dividing rapidly. One common side effect is hair loss, which usually grows back after the first year of treatment. Some side effects can be prevented; most of them are reversible. Occasionally, a child in remission dies from a complication of treatment, usually an overwhelming infection.
Randomized clinical trials that aim to improve the cure rate of leukemia are being conducted by the Children's Oncology Group in most children's hospitals in the United States and Canada. Research on leukemic cells is being carried out in many laboratories throughout the world. The purpose of this research is to develop new strategies to treat leukemia; to determine what changes occur in a cell to cause leukemia; and, ultimately, to prevent a child from developing leukemia.
For more information on acute lymphoblastic leukemia, log on to the following Web sites:
Lilleyman JS. Childhood Leukemia: The Facts. Oxford, England: Oxford University Press; 1994.
Laszlo J. The Cure of Childhood Leukemia: Into the Age of Miracles. New Brunswick, NJ: Rutgers University Press; 1995.
Albano EA, Stork LC, Greffe BS, Odom LF, Foreman NK. Neoplastic disease. In: Hay W, Hayward A, eds. Current Pediatric Diagnosis and Treatment. Stanford, CT: Appleton & Lange; 1999:774-777.
About the Author
Dr. Stork is an associate professor of pediatrics at the University of Colorado Health Sciences Center and The Children's Hospital in Denver. She earned her undergraduate degree from Yale University and her medical degree from Columbia University. Dr. Stork is actively involved in clinical trials that treat children with acute lymphoblastic leukemia.
Copyright 2012 Linda C. Stork, M.D., All Rights Reserved
The information contained in these topics is not intended nor implied to be a substitute for professional medical advice, it is provided for educational purposes only. You assume full responsibility for how you choose to use this information.
Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment or discontinuing an existing treatment. Talk with your healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.
If you think that you are having a medical emergency,
call 911 or the number for the local emergency ambulance service NOW!
And when in doubt, call your doctor NOW
or go to the closest emergency department.
By using this website, you accept the information provided herein "AS IS." Neither RemedyConnect nor the providers of the information contained herein will have any liability to you arising out of your use of the information contained herein or make any express or implied warranty regarding the accuracy, content, completeness, reliability, or efficacy of the information contained within this website.
RemedyConnect, Inc. has created this privacy statement in order to demonstrate our firm commitment to your privacy. The following discloses our information gathering and dissemination practices for this website: http://www.remedyconnect.com.
Acquisition of Information through PMD
We do not acquire any more information about website visitors than is required by law or is otherwise necessary to provide a high level of service efficiently and securely. Our site's registration form requires users to give us contact information (e.g., their name and e-mail address) and demographic information (e.g., children's birth months, but not birth dates). We use customer contact information from the registration form to (1) send the user pertinent medical and parenting information and (2) allow your local health provider lists of who is registering on that provider's site as a parent/guardian, staff member, doctor, or visitor. Users may opt-out of receiving future mailings; see the choice/opt-out section below.
We use your IP address to help diagnose problems with our server and to administer our Website. Your IP address is used to help identify you and to gather broad demographic information.
Demographic and profile data is also collected at our site. We may use this data to tailor the visitor's experience at our site, showing them content that we think they might be interested in, and displaying the content according to their preferences.
Our site may use order forms to allow users to request information, products, and services.
Your Doctor's Right to Privacy
We will respect your doctor's right to privacy. A doctor typically does not give his/her e-mail address to the parents/guardians of patients. We will not provide the e-mail addresses of doctor(s) in the local practice to users of their site without the doctor(s)' permission. Their site is restricted to use by whomever they wish, and they may deny access to their site to one or more prior users. In unusual cases, doctors may change their private site's access code and arrange for us to e-mail the new access code to approved users.
This site contains links to other sites. RemedyConnect.com is not responsible for the privacy practices or the content of such Websites. See Disclaimers.
Disclosure to Third Parties
We will provide individually-identifiable information about website users to third parties only if we are compelled to do so by order of a duly-empowered governmental authority, we have the express permission of the visitor, or it is necessary to process transactions and provide you services from our affiliates: Live Agent Answering Service, Digital Answering Service, Medical Answering Service and Pediatric Answering Service.
Privacy and Our Business Partners
This site may make chat rooms, forums, message boards, and/or news groups available to its users. Please remember that any information that is disclosed in these areas becomes public information and you should exercise caution when deciding to disclose your personal information.
This site has security measures in place to protect the loss, misuse and alteration of the information under our control. For further information regarding our security, please contact us at email@example.com. If you have any concerns regarding the security of information, please do not provide any information to RemedyConnect, Inc. until you are comfortable with our security measures.
You may correct or update your User Registration information at any time, by visiting the User Registration section and providing your personal password that you set at registration. If need be, please email us at firstname.lastname@example.org.
Our site provides users the opportunity to opt-out of receiving e-mail communications from our partners or us, except communications approved by your doctor's practice office. To so opt-out, please email us at email@example.com. To be removed as a user, please email us at the same address. If need be, you may mail requests to us at RemedyConnect, Inc., 9200 E. Mineral Avenue, Suite 100, Centennial, CO 80112. Our telephone number is 303-793-0703.
Contacting the Website
If you have any questions about this privacy statement, the practices of this site, or your dealings with this Website, you can contact us by email at firstname.lastname@example.org or by mail at our address above.